FDA approves libido drug for postmenopausal women
The U.S. Food and Drug Administration approved a prescription pill intended to boost sexual desire in women who have gone through menopause. The nationwide approval means Twin Cities clinicians can consider the new therapy for eligible patients once distribution begins, subject to prescribing guidance and labeling.
📌 Key Facts
- Regulator: U.S. Food and Drug Administration
- Action: Approval of a libido‑boosting pill for postmenopausal women
- Date: Dec. 15, 2025; approval applies nationwide, including Minnesota